Dave Luckenbaugh

530 total citations
6 papers, 388 citations indexed

About

Dave Luckenbaugh is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dave Luckenbaugh has authored 6 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 2 papers in Psychiatry and Mental health and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Dave Luckenbaugh's work include Treatment of Major Depression (2 papers), Stress Responses and Cortisol (1 paper) and Motor Control and Adaptation (1 paper). Dave Luckenbaugh is often cited by papers focused on Treatment of Major Depression (2 papers), Stress Responses and Cortisol (1 paper) and Motor Control and Adaptation (1 paper). Dave Luckenbaugh collaborates with scholars based in United States, Sweden and Israel. Dave Luckenbaugh's co-authors include Mitsunari Abe, Leonardo G. Cohen, Heidi M. Schambra, Nicolas Schweighofer, Eric M. Wassermann, Carlos A. Zarate, Irving W. Wainer, Nancy E. Brutsché, Swarajya Lakshmi Vattem Venkata and Lobna Ibrahim and has published in prestigious journals such as NeuroImage, Current Biology and Biological Psychiatry.

In The Last Decade

Dave Luckenbaugh

6 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dave Luckenbaugh United States 5 192 114 79 79 73 6 388
Jean-Marie Batail France 13 313 1.6× 40 0.4× 65 0.8× 17 0.2× 25 0.3× 32 484
Maria Ironside United States 13 299 1.6× 30 0.3× 69 0.9× 66 0.8× 35 0.5× 29 578
Francesco Di Gregorio Italy 12 354 1.8× 24 0.2× 37 0.5× 40 0.5× 22 0.3× 28 495
Chris Petty United States 7 264 1.4× 53 0.5× 31 0.4× 13 0.2× 11 0.2× 7 332
Christina G. Baehne Germany 10 423 2.2× 24 0.2× 76 1.0× 68 0.9× 11 0.2× 13 795
Joel Ellwanger United States 9 295 1.5× 57 0.5× 86 1.1× 189 2.4× 13 0.2× 15 567
Ruiyang Ge Canada 15 459 2.4× 64 0.6× 24 0.3× 24 0.3× 25 0.3× 43 610
Marion Kühn Germany 14 595 3.1× 38 0.3× 97 1.2× 18 0.2× 31 0.4× 25 790
Numan Ermutlu Türkiye 9 215 1.1× 69 0.6× 52 0.7× 20 0.3× 5 0.1× 13 371
Alexander S. Korb United States 12 329 1.7× 132 1.2× 38 0.5× 13 0.2× 31 0.4× 18 558

Countries citing papers authored by Dave Luckenbaugh

Since Specialization
Citations

This map shows the geographic impact of Dave Luckenbaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dave Luckenbaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dave Luckenbaugh more than expected).

Fields of papers citing papers by Dave Luckenbaugh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dave Luckenbaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dave Luckenbaugh. The network helps show where Dave Luckenbaugh may publish in the future.

Co-authorship network of co-authors of Dave Luckenbaugh

This figure shows the co-authorship network connecting the top 25 collaborators of Dave Luckenbaugh. A scholar is included among the top collaborators of Dave Luckenbaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dave Luckenbaugh. Dave Luckenbaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Freedman, Nanette, Hava Lester, Yoram Louzoun, et al.. (2012). Brain activation and heart rate during script-driven traumatic imagery in PTSD: Preliminary findings. Psychiatry Research Neuroimaging. 204(2-3). 155–160. 16 indexed citations
2.
Zhao, Xiaochen, Swarajya Lakshmi Vattem Venkata, Ruin Moaddel, et al.. (2012). Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment‐resistant bipolar depression. British Journal of Clinical Pharmacology. 74(2). 304–314. 113 indexed citations
3.
Abe, Mitsunari, Heidi M. Schambra, Eric M. Wassermann, et al.. (2011). Reward Improves Long-Term Retention of a Motor Memory through Induction of Offline Memory Gains. Current Biology. 21(7). 557–562. 227 indexed citations
4.
Carlson, Paul J., Earle Bain, Allison C. Nugent, et al.. (2008). Relationship between serotonin-1A binding and HPA axis in subjects with major depression and healthy controls. NeuroImage. 41. T146–T146. 3 indexed citations
5.
Post, Robert M., et al.. (2000). Neuropsychological Deficits of Primary Affective Illness: Implications for Therapy. Psychiatric Annals. 30(7). 485–494. 4 indexed citations
6.
Little, John T., Terence A. Ketter, Aleksander A. Mathé, et al.. (1999). Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression. Biological Psychiatry. 45(3). 285–289. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026